2024
Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.
Bromberg D, Madden L, Fraenkel L, Muthulingam D, Rhoades D, Dvoriak S, Dumchev K, Pykalo I, Altice F. Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey. PLOS Global Public Health 2024, 4: e0002725. PMID: 38277422, PMCID: PMC10817130, DOI: 10.1371/journal.pgph.0002725.Peer-Reviewed Original ResearchOpioid agonist therapyWithdrawal symptomsAdverse side effectsAgonist therapySide effectsOpioid use disorderQuality-of-life improvementUse disorderCombined HIVHIV incidenceClinical decision-makingDosing frequencyRespondent-driven samplingOpioidOpioid epidemicAssess preferencesClinical concernPatient preferencesPatientsDelivery strategiesTherapyDisordersHIVPatient concernsWithdrawal
2018
Characteristics of Surrogate Decision Makers Selecting Life-sustaining Therapy for Severe Intracerebral Hemorrhage Patients: a Neuropalliative Care Survey of the US Population (S7.003)
Hwang D, Knies A, White D, Holloway R, Sheth K, Fraenkel L. Characteristics of Surrogate Decision Makers Selecting Life-sustaining Therapy for Severe Intracerebral Hemorrhage Patients: a Neuropalliative Care Survey of the US Population (S7.003). Neurology 2018, 90 DOI: 10.1212/wnl.90.15_supplement.s7.003.Peer-Reviewed Original Research
2012
Decision tool to improve the quality of care in rheumatoid arthritis
Fraenkel L, Peters E, Charpentier P, Olsen B, Errante L, Schoen RT, Reyna V. Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care & Research 2012, 64: 977-985. PMID: 22392766, PMCID: PMC3375390, DOI: 10.1002/acr.21657.Peer-Reviewed Original ResearchConceptsRheumatoid arthritisBiologic therapyDisease-modifying antirheumatic drugsOngoing active diseaseProportion of subjectsQuality of careActive diseaseAntirheumatic drugsRA patientsClinical trialsPatients' willingnessClinical practiceClarity of valuesValues clarityBiologicsArthritisPatientsTherapyPreliminary evidencePerceived knowledgeCareEfficacyRiskSubjectsDisease
2009
Racial Disparities in Treatment Preferences for Rheumatoid Arthritis
Constantinescu F, Goucher S, Weinstein A, Fraenkel L. Racial Disparities in Treatment Preferences for Rheumatoid Arthritis. Medical Care 2009, 47: 350-355. PMID: 19165120, PMCID: PMC3682220, DOI: 10.1097/mlr.0b013e31818af829.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntirheumatic AgentsArthritis, RheumatoidBlack or African AmericanCommunicationDecision MakingDistrict of ColumbiaFemaleHealth Knowledge, Attitudes, PracticeHealthcare DisparitiesHumansInterviews as TopicMaleMedication AdherenceMethotrexateMiddle AgedOutpatient Clinics, HospitalPatient SatisfactionPsychometricsRheumatologySocioeconomic FactorsSoftwareTumor Necrosis Factor-alphaVirginiaWhite PeopleYoung AdultConceptsAggressive therapyRheumatoid arthritisTreatment preferencesAggressive treatmentChronic diseasesRacial disparitiesConsecutive eligible patientsLong-term outcomesAvailable treatment optionsBest available treatment optionsImportant clinical implicationsSimilar disease severityEligible patientsWhite patientsBlack patientsTreatment optionsUnadjusted analysesPatient preferencesPhysician communicationPatient educationPatientsDisease severityMedical interventionsClinical implicationsTherapy